Sun Pharmaceutical Industries Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|
Revenue | 6,260.20 | 5,214.01 | 4,580.81 |
Operating Expense | 4,488.34 | 3,789.09 | 3,737 |
Net Profit | 1,181.05 | 863.29 | 237.82 |
Net Profit Margin | 18.87 | 16.56 | 5.19 |
Earning Per Share | 4.90 | 3.60 | 1 |
EBIDTA | 1,771.86 | 1,424.92 | 843.81 |
Effective Tax Rate | 4.73 | 2.27 | 2.38 |
Particulars | Dec 2024 |
---|---|
Revenue | 6260.20 |
Operating Expense | 4488.34 |
Net Profit | 1181.05 |
Net Profit Margin | 18.87 |
Earning Per Share | 4.90 |
EBIDTA | 1771.86 |
Effective Tax Rate | 4.73 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | 20,275.17 | 20,812.14 | 15,585.98 |
Operating Expenses Annual | 14,775.28 | 14,389.54 | 12,917.42 |
Operating Profit Annual | 5,834.35 | 3,814.10 | 2,044.91 |
Interest Annual | 784.08 | 472.18 | 388.10 |
Depreciation | 1,600.62 | 1,600.87 | 1,349.95 |
Net Profit Annual | 2,858.18 | 1,690.72 | -99.99 |
Tax Annual | 591.47 | 50.33 | 406.85 |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | 20,275.17 |
Operating Expenses Annual | 14,775.28 |
Operating Profit Annual | 5,834.35 |
Interest Annual | 784.08 |
Depreciation | 1,600.62 |
Net Profit Annual | 2,858.18 |
Tax Annual | 591.47 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 410.28 | 419.53 | 351.06 |
Cash Flow from Operations | -292.42 | 507.08 | 7,636.36 |
Cash Flow from Investing | -265.35 | -685.64 | -2,697.04 |
Cash Flow from Financing | 473.95 | 169.31 | -4,870.85 |
Cash Flow at the End | 326.46 | 410.28 | 419.53 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 410.28 |
Cash Flow from Operations | -292.42 |
Cash Flow from Investing | -265.35 |
Cash Flow from Financing | 473.95 |
Cash Flow at the End | 326.46 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | 28.78 | 32.43 | 24.56 |
PBIT Margin (%) | 20.88 | 24.73 | 15.90 |
PBT Margin (%) | 20.85 | 24.68 | 15.86 |
Net PROFIT Margin (%) | 14.10 | 8.12 | -0.64 |
Return On Networth / Equity (%) | 12.05 | 13.89 | -5.19 |
Return On Networth /Employed (%) | 12.22 | 16.26 | 7.47 |
Return On Assets (%) | 8.32 | 5.36 | -0.30 |
Total Debt / Equity (X) | 0.40 | 0.27 | 0.24 |
Asset Turnover Ratio (%) | 0.59 | 0.66 | 0.47 |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | 28.78 |
PBIT Margin (%) | 20.88 |
PBT Margin (%) | 20.85 |
Net PROFIT Margin (%) | 14.10 |
Return On Networth / Equity (%) | 12.05 |
Return On Networth /Employed (%) | 12.22 |
Return On Assets (%) | 8.32 |
Total Debt / Equity (X) | 0.40 |
Asset Turnover Ratio (%) | 0.59 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 8,114.61 | 9,235.71 | 10,182.48 |
Total Current Assets Annual | 14,912.54 | 16,443.75 | 9,703.75 |
Non Current Assets Annual | 26,110.38 | 24,522.34 | 31,061.73 |
Total Shareholders Funds Annual | 23,694.40 | 23,748.36 | 24,587.95 |
Total Assets Annual | 41,064.79 | 40,987.49 | 40,765.48 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 8,114.61 |
Total Current Assets Annual | 14,912.54 |
Non Current Assets Annual | 26,110.38 |
Total Shareholders Funds Annual | 23,694.40 |
Total Assets Annual | 41,064.79 |
EPS (INR)
Expected
12.10
Reported
12.10
Surprise
0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.24%
Mar 2024
EPS beaten by -0.17%